Trademark: 86724545
Status Date
Monday, February 4, 2019
Filing Date
Thursday, August 13, 2015
Published for Opposition
Tuesday, November 3, 2015
Abandoned Date
Monday, February 4, 2019
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Feb 4, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 4, 2019
Abandonment - No Use Statement Filed
Jun 19, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 18, 2018
Extension 5 Granted
Jun 14, 2018
Extension 5 Filed
Jun 14, 2018
Teas Extension Received
Jan 3, 2018
Assignment Of Ownership Not Updated Automatically
Dec 5, 2017
Notice Of Approval Of Extension Request E-Mailed
Dec 1, 2017
Extension 4 Granted
Dec 1, 2017
Extension 4 Filed
Dec 1, 2017
Teas Extension Received
Jun 28, 2017
Automatic Update Of Assignment Of Ownership
Jun 16, 2017
Notice Of Approval Of Extension Request E-Mailed
Jun 15, 2017
Extension 3 Granted
Jun 12, 2017
Extension 3 Filed
Jun 12, 2017
Teas Extension Received
Jan 30, 2017
Teas Change Of Correspondence Received
Dec 24, 2016
Notice Of Approval Of Extension Request E-Mailed
Dec 23, 2016
Extension 2 Granted
Dec 2, 2016
Extension 2 Filed
Dec 22, 2016
Case Assigned To Intent To Use Paralegal
Dec 2, 2016
Teas Extension Received
Jun 28, 2016
Notice Of Approval Of Extension Request E-Mailed
Jun 24, 2016
Extension 1 Granted
Jun 24, 2016
Extension 1 Filed
Jun 24, 2016
Teas Extension Received
Dec 29, 2015
Noa E-Mailed - Sou Required From Applicant
Nov 3, 2015
Official Gazette Publication Confirmation E-Mailed
Nov 3, 2015
Published For Opposition
Oct 14, 2015
Notification Of Notice Of Publication E-Mailed
Sep 21, 2015
Approved For Pub - Principal Register
Sep 21, 2015
Assigned To Examiner
Aug 19, 2015
New Application Office Supplied Data Entered In Tram
Aug 17, 2015
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
